Literature DB >> 10994470

Keratoacanthoma: the Australian experience.

J J Sullivan1.   

Abstract

Comment is offered on the roughly 50 years experience of Australian clinicians with the various types of keratoacanthoma, and local contributions to knowledge in this area is indicated. The higher incidence in warmer areas, with consequent early acceptance of the entity, is documented. Effects of immunosuppression are recorded, and viral and immunological studies noted. Aspects of special sub-groups, such as multiple and subungual, and of treatment, are briefly discussed, and future areas of research mentioned.

Entities:  

Mesh:

Year:  1997        PMID: 10994470     DOI: 10.1111/j.1440-0960.1997.tb01007.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  4 in total

1.  Periocular keratoacanthoma: can we always rely on the clinical diagnosis?

Authors:  I Leibovitch; S C Huilgol; C L James; J D Hsuan; G Davis; D Selva
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Double localization of keratoacantho-ma on the cutaneous and mucosal sides of the lower lip: report of a case.

Authors:  M P Cristalli; R Marini; G LA Monaca; D Vitolo; G Pompa; S Annibali
Journal:  Oral Implantol (Rome)       Date:  2014-05-19

3.  Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia.

Authors:  Magdalena Claeson; Nirmala Pandeya; Jean-Claude Dusingize; Bridie S Thompson; Adele C Green; Rachel E Neale; Catherine M Olsen; David C Whiteman
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282

Review 4.  Keratoacanthoma of the inferior lip: review and report of case with spontaneous regression.

Authors:  Lara Maria A Ramos; Sérgio V Cardoso; Adriano M Loyola; Marcus A Rocha; Antônio Francisco Durighetto-Júnior
Journal:  J Appl Oral Sci       Date:  2009 May-Jun       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.